0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaginal Anti Infectives Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-23A15174
Home | Market Reports | Health| Reproductive Health
Global Vaginal Anti Infectives Market Research Report 2023
BUY CHAPTERS

Global Vaginal Anti Infectives Market Research Report 2024

Code: QYRE-Auto-23A15174
Report
July 2024
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vaginal Anti Infectives Market Size

The global Vaginal Anti Infectives market was valued at US$ 3120 million in 2023 and is anticipated to reach US$ 4356.5 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.

Vaginal Anti Infectives Market

Vaginal Anti Infectives Market

Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. "Yeast" infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
North American market for Vaginal Anti Infectives is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vaginal Anti Infectives is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Vaginal Anti Infectives include Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, AbbVie Inc, Melinta Therapeutics, Inc, Bristol-Myers Squibb Company and GSK plc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vaginal Anti Infectives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaginal Anti Infectives.

Report Scope

The Vaginal Anti Infectives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaginal Anti Infectives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaginal Anti Infectives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Vaginal Anti Infectives Market Report

Report Metric Details
Report Name Vaginal Anti Infectives Market
Accounted market size in 2023 US$ 3120 million
Forecasted market size in 2030 US$ 4356.5 million
CAGR 5.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Oral
  • Ointment
Segment by Application
  • Bacterial Vaginitis
  • Trichomonal Vaginitis
  • Candida Vaginitis
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, AbbVie Inc, Melinta Therapeutics, Inc, Bristol-Myers Squibb Company, GSK plc, Bayer AG, Lupin, Perrigo Company plc, Bayer, Sanofi, Scynexis, Bausch Health Companies Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vaginal Anti Infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vaginal Anti Infectives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Vaginal Anti Infectives Market growing?

Ans: The Vaginal Anti Infectives Market witnessing a CAGR of 5.2% during the forecast period 2024-2030.

What is the Vaginal Anti Infectives Market size in 2030?

Ans: The Vaginal Anti Infectives Market size in 2030 will be US$ 4356.5 million.

Who are the main players in the Vaginal Anti Infectives Market report?

Ans: The main players in the Vaginal Anti Infectives Market are Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, AbbVie Inc, Melinta Therapeutics, Inc, Bristol-Myers Squibb Company, GSK plc, Bayer AG, Lupin, Perrigo Company plc, Bayer, Sanofi, Scynexis, Bausch Health Companies Inc

What are the Application segmentation covered in the Vaginal Anti Infectives Market report?

Ans: The Applications covered in the Vaginal Anti Infectives Market report are Bacterial Vaginitis, Trichomonal Vaginitis, Candida Vaginitis

What are the Type segmentation covered in the Vaginal Anti Infectives Market report?

Ans: The Types covered in the Vaginal Anti Infectives Market report are Oral, Ointment

1 Vaginal Anti Infectives Market Overview
1.1 Product Overview and Scope of Vaginal Anti Infectives
1.2 Vaginal Anti Infectives Segment by Type
1.2.1 Global Vaginal Anti Infectives Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Ointment
1.3 Vaginal Anti Infectives Segment by Application
1.3.1 Global Vaginal Anti Infectives Market Value by Application: (2024-2030)
1.3.2 Bacterial Vaginitis
1.3.3 Trichomonal Vaginitis
1.3.4 Candida Vaginitis
1.4 Global Vaginal Anti Infectives Market Size Estimates and Forecasts
1.4.1 Global Vaginal Anti Infectives Revenue 2019-2030
1.4.2 Global Vaginal Anti Infectives Sales 2019-2030
1.4.3 Global Vaginal Anti Infectives Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vaginal Anti Infectives Market Competition by Manufacturers
2.1 Global Vaginal Anti Infectives Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vaginal Anti Infectives Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vaginal Anti Infectives Average Price by Manufacturers (2019-2024)
2.4 Global Vaginal Anti Infectives Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaginal Anti Infectives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaginal Anti Infectives, Product Type & Application
2.7 Vaginal Anti Infectives Market Competitive Situation and Trends
2.7.1 Vaginal Anti Infectives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaginal Anti Infectives Players Market Share by Revenue
2.7.3 Global Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaginal Anti Infectives Retrospective Market Scenario by Region
3.1 Global Vaginal Anti Infectives Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vaginal Anti Infectives Global Vaginal Anti Infectives Sales by Region: 2019-2030
3.2.1 Global Vaginal Anti Infectives Sales by Region: 2019-2024
3.2.2 Global Vaginal Anti Infectives Sales by Region: 2025-2030
3.3 Global Vaginal Anti Infectives Global Vaginal Anti Infectives Revenue by Region: 2019-2030
3.3.1 Global Vaginal Anti Infectives Revenue by Region: 2019-2024
3.3.2 Global Vaginal Anti Infectives Revenue by Region: 2025-2030
3.4 North America Vaginal Anti Infectives Market Facts & Figures by Country
3.4.1 North America Vaginal Anti Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vaginal Anti Infectives Sales by Country (2019-2030)
3.4.3 North America Vaginal Anti Infectives Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaginal Anti Infectives Market Facts & Figures by Country
3.5.1 Europe Vaginal Anti Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vaginal Anti Infectives Sales by Country (2019-2030)
3.5.3 Europe Vaginal Anti Infectives Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaginal Anti Infectives Market Facts & Figures by Country
3.6.1 Asia Pacific Vaginal Anti Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vaginal Anti Infectives Sales by Country (2019-2030)
3.6.3 Asia Pacific Vaginal Anti Infectives Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaginal Anti Infectives Market Facts & Figures by Country
3.7.1 Latin America Vaginal Anti Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vaginal Anti Infectives Sales by Country (2019-2030)
3.7.3 Latin America Vaginal Anti Infectives Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaginal Anti Infectives Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaginal Anti Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vaginal Anti Infectives Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vaginal Anti Infectives Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaginal Anti Infectives Sales by Type (2019-2030)
4.1.1 Global Vaginal Anti Infectives Sales by Type (2019-2024)
4.1.2 Global Vaginal Anti Infectives Sales by Type (2025-2030)
4.1.3 Global Vaginal Anti Infectives Sales Market Share by Type (2019-2030)
4.2 Global Vaginal Anti Infectives Revenue by Type (2019-2030)
4.2.1 Global Vaginal Anti Infectives Revenue by Type (2019-2024)
4.2.2 Global Vaginal Anti Infectives Revenue by Type (2025-2030)
4.2.3 Global Vaginal Anti Infectives Revenue Market Share by Type (2019-2030)
4.3 Global Vaginal Anti Infectives Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vaginal Anti Infectives Sales by Application (2019-2030)
5.1.1 Global Vaginal Anti Infectives Sales by Application (2019-2024)
5.1.2 Global Vaginal Anti Infectives Sales by Application (2025-2030)
5.1.3 Global Vaginal Anti Infectives Sales Market Share by Application (2019-2030)
5.2 Global Vaginal Anti Infectives Revenue by Application (2019-2030)
5.2.1 Global Vaginal Anti Infectives Revenue by Application (2019-2024)
5.2.2 Global Vaginal Anti Infectives Revenue by Application (2025-2030)
5.2.3 Global Vaginal Anti Infectives Revenue Market Share by Application (2019-2030)
5.3 Global Vaginal Anti Infectives Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Corporation Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Inc Vaginal Anti Infectives Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Mylan N.V
6.2.1 Mylan N.V Corporation Information
6.2.2 Mylan N.V Description and Business Overview
6.2.3 Mylan N.V Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan N.V Vaginal Anti Infectives Product Portfolio
6.2.5 Mylan N.V Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis AG Vaginal Anti Infectives Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Hikma Pharmaceuticals plc
6.4.1 Hikma Pharmaceuticals plc Corporation Information
6.4.2 Hikma Pharmaceuticals plc Description and Business Overview
6.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Portfolio
6.4.5 Hikma Pharmaceuticals plc Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aurobindo Pharma Vaginal Anti Infectives Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 AbbVie Inc
6.6.1 AbbVie Inc Corporation Information
6.6.2 AbbVie Inc Description and Business Overview
6.6.3 AbbVie Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AbbVie Inc Vaginal Anti Infectives Product Portfolio
6.6.5 AbbVie Inc Recent Developments/Updates
6.7 Melinta Therapeutics, Inc
6.6.1 Melinta Therapeutics, Inc Corporation Information
6.6.2 Melinta Therapeutics, Inc Description and Business Overview
6.6.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Portfolio
6.7.5 Melinta Therapeutics, Inc Recent Developments/Updates
6.8 Bristol-Myers Squibb Company
6.8.1 Bristol-Myers Squibb Company Corporation Information
6.8.2 Bristol-Myers Squibb Company Description and Business Overview
6.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Portfolio
6.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.9 GSK plc
6.9.1 GSK plc Corporation Information
6.9.2 GSK plc Description and Business Overview
6.9.3 GSK plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GSK plc Vaginal Anti Infectives Product Portfolio
6.9.5 GSK plc Recent Developments/Updates
6.10 Bayer AG
6.10.1 Bayer AG Corporation Information
6.10.2 Bayer AG Description and Business Overview
6.10.3 Bayer AG Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bayer AG Vaginal Anti Infectives Product Portfolio
6.10.5 Bayer AG Recent Developments/Updates
6.11 Lupin
6.11.1 Lupin Corporation Information
6.11.2 Lupin Vaginal Anti Infectives Description and Business Overview
6.11.3 Lupin Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lupin Vaginal Anti Infectives Product Portfolio
6.11.5 Lupin Recent Developments/Updates
6.12 Perrigo Company plc
6.12.1 Perrigo Company plc Corporation Information
6.12.2 Perrigo Company plc Vaginal Anti Infectives Description and Business Overview
6.12.3 Perrigo Company plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Perrigo Company plc Vaginal Anti Infectives Product Portfolio
6.12.5 Perrigo Company plc Recent Developments/Updates
6.13 Bayer
6.13.1 Bayer Corporation Information
6.13.2 Bayer Vaginal Anti Infectives Description and Business Overview
6.13.3 Bayer Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Bayer Vaginal Anti Infectives Product Portfolio
6.13.5 Bayer Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Corporation Information
6.14.2 Sanofi Vaginal Anti Infectives Description and Business Overview
6.14.3 Sanofi Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sanofi Vaginal Anti Infectives Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Scynexis
6.15.1 Scynexis Corporation Information
6.15.2 Scynexis Vaginal Anti Infectives Description and Business Overview
6.15.3 Scynexis Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Scynexis Vaginal Anti Infectives Product Portfolio
6.15.5 Scynexis Recent Developments/Updates
6.16 Bausch Health Companies Inc
6.16.1 Bausch Health Companies Inc Corporation Information
6.16.2 Bausch Health Companies Inc Vaginal Anti Infectives Description and Business Overview
6.16.3 Bausch Health Companies Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Bausch Health Companies Inc Vaginal Anti Infectives Product Portfolio
6.16.5 Bausch Health Companies Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaginal Anti Infectives Industry Chain Analysis
7.2 Vaginal Anti Infectives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaginal Anti Infectives Production Mode & Process
7.4 Vaginal Anti Infectives Sales and Marketing
7.4.1 Vaginal Anti Infectives Sales Channels
7.4.2 Vaginal Anti Infectives Distributors
7.5 Vaginal Anti Infectives Customers
8 Vaginal Anti Infectives Market Dynamics
8.1 Vaginal Anti Infectives Industry Trends
8.2 Vaginal Anti Infectives Market Drivers
8.3 Vaginal Anti Infectives Market Challenges
8.4 Vaginal Anti Infectives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Vaginal Anti Infectives Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Vaginal Anti Infectives Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Vaginal Anti Infectives Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Vaginal Anti Infectives Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Vaginal Anti Infectives Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Vaginal Anti Infectives Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Vaginal Anti Infectives Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Vaginal Anti Infectives Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Vaginal Anti Infectives, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Vaginal Anti Infectives, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Vaginal Anti Infectives, Product Type & Application
    Table 12. Global Key Manufacturers of Vaginal Anti Infectives, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Vaginal Anti Infectives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Anti Infectives as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Vaginal Anti Infectives Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Vaginal Anti Infectives Sales by Region (2019-2024) & (K Units)
    Table 18. Global Vaginal Anti Infectives Sales Market Share by Region (2019-2024)
    Table 19. Global Vaginal Anti Infectives Sales by Region (2025-2030) & (K Units)
    Table 20. Global Vaginal Anti Infectives Sales Market Share by Region (2025-2030)
    Table 21. Global Vaginal Anti Infectives Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Vaginal Anti Infectives Revenue Market Share by Region (2019-2024)
    Table 23. Global Vaginal Anti Infectives Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Vaginal Anti Infectives Revenue Market Share by Region (2025-2030)
    Table 25. North America Vaginal Anti Infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Vaginal Anti Infectives Sales by Country (2019-2024) & (K Units)
    Table 27. North America Vaginal Anti Infectives Sales by Country (2025-2030) & (K Units)
    Table 28. North America Vaginal Anti Infectives Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Vaginal Anti Infectives Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Vaginal Anti Infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Vaginal Anti Infectives Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Vaginal Anti Infectives Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Vaginal Anti Infectives Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Vaginal Anti Infectives Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Vaginal Anti Infectives Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Vaginal Anti Infectives Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Vaginal Anti Infectives Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Vaginal Anti Infectives Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Vaginal Anti Infectives Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Vaginal Anti Infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Vaginal Anti Infectives Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Vaginal Anti Infectives Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Vaginal Anti Infectives Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Vaginal Anti Infectives Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Vaginal Anti Infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Vaginal Anti Infectives Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Vaginal Anti Infectives Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Vaginal Anti Infectives Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Vaginal Anti Infectives Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Vaginal Anti Infectives Sales (K Units) by Type (2019-2024)
    Table 51. Global Vaginal Anti Infectives Sales (K Units) by Type (2025-2030)
    Table 52. Global Vaginal Anti Infectives Sales Market Share by Type (2019-2024)
    Table 53. Global Vaginal Anti Infectives Sales Market Share by Type (2025-2030)
    Table 54. Global Vaginal Anti Infectives Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Vaginal Anti Infectives Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Vaginal Anti Infectives Revenue Market Share by Type (2019-2024)
    Table 57. Global Vaginal Anti Infectives Revenue Market Share by Type (2025-2030)
    Table 58. Global Vaginal Anti Infectives Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Vaginal Anti Infectives Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Vaginal Anti Infectives Sales (K Units) by Application (2019-2024)
    Table 61. Global Vaginal Anti Infectives Sales (K Units) by Application (2025-2030)
    Table 62. Global Vaginal Anti Infectives Sales Market Share by Application (2019-2024)
    Table 63. Global Vaginal Anti Infectives Sales Market Share by Application (2025-2030)
    Table 64. Global Vaginal Anti Infectives Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Vaginal Anti Infectives Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Vaginal Anti Infectives Revenue Market Share by Application (2019-2024)
    Table 67. Global Vaginal Anti Infectives Revenue Market Share by Application (2025-2030)
    Table 68. Global Vaginal Anti Infectives Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Vaginal Anti Infectives Price (US$/Unit) by Application (2025-2030)
    Table 70. Pfizer Inc Corporation Information
    Table 71. Pfizer Inc Description and Business Overview
    Table 72. Pfizer Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Pfizer Inc Vaginal Anti Infectives Product
    Table 74. Pfizer Inc Recent Developments/Updates
    Table 75. Mylan N.V Corporation Information
    Table 76. Mylan N.V Description and Business Overview
    Table 77. Mylan N.V Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Mylan N.V Vaginal Anti Infectives Product
    Table 79. Mylan N.V Recent Developments/Updates
    Table 80. Novartis AG Corporation Information
    Table 81. Novartis AG Description and Business Overview
    Table 82. Novartis AG Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Novartis AG Vaginal Anti Infectives Product
    Table 84. Novartis AG Recent Developments/Updates
    Table 85. Hikma Pharmaceuticals plc Corporation Information
    Table 86. Hikma Pharmaceuticals plc Description and Business Overview
    Table 87. Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product
    Table 89. Hikma Pharmaceuticals plc Recent Developments/Updates
    Table 90. Aurobindo Pharma Corporation Information
    Table 91. Aurobindo Pharma Description and Business Overview
    Table 92. Aurobindo Pharma Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Aurobindo Pharma Vaginal Anti Infectives Product
    Table 94. Aurobindo Pharma Recent Developments/Updates
    Table 95. AbbVie Inc Corporation Information
    Table 96. AbbVie Inc Description and Business Overview
    Table 97. AbbVie Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. AbbVie Inc Vaginal Anti Infectives Product
    Table 99. AbbVie Inc Recent Developments/Updates
    Table 100. Melinta Therapeutics, Inc Corporation Information
    Table 101. Melinta Therapeutics, Inc Description and Business Overview
    Table 102. Melinta Therapeutics, Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Melinta Therapeutics, Inc Vaginal Anti Infectives Product
    Table 104. Melinta Therapeutics, Inc Recent Developments/Updates
    Table 105. Bristol-Myers Squibb Company Corporation Information
    Table 106. Bristol-Myers Squibb Company Description and Business Overview
    Table 107. Bristol-Myers Squibb Company Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Bristol-Myers Squibb Company Vaginal Anti Infectives Product
    Table 109. Bristol-Myers Squibb Company Recent Developments/Updates
    Table 110. GSK plc Corporation Information
    Table 111. GSK plc Description and Business Overview
    Table 112. GSK plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. GSK plc Vaginal Anti Infectives Product
    Table 114. GSK plc Recent Developments/Updates
    Table 115. Bayer AG Corporation Information
    Table 116. Bayer AG Description and Business Overview
    Table 117. Bayer AG Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Bayer AG Vaginal Anti Infectives Product
    Table 119. Bayer AG Recent Developments/Updates
    Table 120. Lupin Corporation Information
    Table 121. Lupin Description and Business Overview
    Table 122. Lupin Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Lupin Vaginal Anti Infectives Product
    Table 124. Lupin Recent Developments/Updates
    Table 125. Perrigo Company plc Corporation Information
    Table 126. Perrigo Company plc Description and Business Overview
    Table 127. Perrigo Company plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Perrigo Company plc Vaginal Anti Infectives Product
    Table 129. Perrigo Company plc Recent Developments/Updates
    Table 130. Bayer Corporation Information
    Table 131. Bayer Description and Business Overview
    Table 132. Bayer Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Bayer Vaginal Anti Infectives Product
    Table 134. Bayer Recent Developments/Updates
    Table 135. Sanofi Corporation Information
    Table 136. Sanofi Description and Business Overview
    Table 137. Sanofi Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Sanofi Vaginal Anti Infectives Product
    Table 139. Sanofi Recent Developments/Updates
    Table 140. Scynexis Corporation Information
    Table 141. Scynexis Description and Business Overview
    Table 142. Scynexis Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Scynexis Vaginal Anti Infectives Product
    Table 144. Scynexis Recent Developments/Updates
    Table 145. Bausch Health Companies Inc Corporation Information
    Table 146. Bausch Health Companies Inc Description and Business Overview
    Table 147. Bausch Health Companies Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Bausch Health Companies Inc Vaginal Anti Infectives Product
    Table 149. Bausch Health Companies Inc Recent Developments/Updates
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Vaginal Anti Infectives Distributors List
    Table 153. Vaginal Anti Infectives Customers List
    Table 154. Vaginal Anti Infectives Market Trends
    Table 155. Vaginal Anti Infectives Market Drivers
    Table 156. Vaginal Anti Infectives Market Challenges
    Table 157. Vaginal Anti Infectives Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Vaginal Anti Infectives
    Figure 2. Global Vaginal Anti Infectives Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Vaginal Anti Infectives Market Share by Type in 2023 & 2030
    Figure 4. Oral Product Picture
    Figure 5. Ointment Product Picture
    Figure 6. Global Vaginal Anti Infectives Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Vaginal Anti Infectives Market Share by Application in 2023 & 2030
    Figure 8. Bacterial Vaginitis
    Figure 9. Trichomonal Vaginitis
    Figure 10. Candida Vaginitis
    Figure 11. Global Vaginal Anti Infectives Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Vaginal Anti Infectives Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Vaginal Anti Infectives Sales (2019-2030) & (K Units)
    Figure 14. Global Vaginal Anti Infectives Average Price (US$/Unit) & (2019-2030)
    Figure 15. Vaginal Anti Infectives Report Years Considered
    Figure 16. Vaginal Anti Infectives Sales Share by Manufacturers in 2023
    Figure 17. Global Vaginal Anti Infectives Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Vaginal Anti Infectives Players: Market Share by Revenue in 2023
    Figure 19. Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Vaginal Anti Infectives Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Vaginal Anti Infectives Sales Market Share by Country (2019-2030)
    Figure 22. North America Vaginal Anti Infectives Revenue Market Share by Country (2019-2030)
    Figure 23. United States Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Vaginal Anti Infectives Sales Market Share by Country (2019-2030)
    Figure 26. Europe Vaginal Anti Infectives Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Vaginal Anti Infectives Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Vaginal Anti Infectives Revenue Market Share by Region (2019-2030)
    Figure 34. China Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. China Taiwan Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Southeast Asia Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Latin America Vaginal Anti Infectives Sales Market Share by Country (2019-2030)
    Figure 42. Latin America Vaginal Anti Infectives Revenue Market Share by Country (2019-2030)
    Figure 43. Mexico Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Brazil Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Argentina Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Vaginal Anti Infectives Sales Market Share by Country (2019-2030)
    Figure 47. Middle East & Africa Vaginal Anti Infectives Revenue Market Share by Country (2019-2030)
    Figure 48. Turkey Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Saudi Arabia Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. UAE Vaginal Anti Infectives Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Global Sales Market Share of Vaginal Anti Infectives by Type (2019-2030)
    Figure 52. Global Revenue Market Share of Vaginal Anti Infectives by Type (2019-2030)
    Figure 53. Global Vaginal Anti Infectives Price (US$/Unit) by Type (2019-2030)
    Figure 54. Global Sales Market Share of Vaginal Anti Infectives by Application (2019-2030)
    Figure 55. Global Revenue Market Share of Vaginal Anti Infectives by Application (2019-2030)
    Figure 56. Global Vaginal Anti Infectives Price (US$/Unit) by Application (2019-2030)
    Figure 57. Vaginal Anti Infectives Value Chain
    Figure 58. Vaginal Anti Infectives Production Process
    Figure 59. Channels of Distribution (Direct Vs Distribution)
    Figure 60. Distributors Profiles
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS